Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Urolithiasis × Clear all

Status

Sponsor Class

OTHER 4 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 2834 Carcinoma, Non-Small-Cell Lung 2377 Breast Neoplasms 2235 Colorectal Neoplasms 1244 Prostatic Neoplasms 1149 Neoplasm Metastasis 1142 Multiple Myeloma 966 Melanoma 965 Ovarian Neoplasms 876 Recurrence 813 Lung Neoplasms 810 Leukemia, Myeloid, Acute 776 Pancreatic Neoplasms 720 Lymphoma, Non-Hodgkin 666 Lymphoma 633 Stomach Neoplasms 598 Carcinoma, Renal Cell 579 Carcinoma, Hepatocellular 560 Leukemia, Lymphocytic, Chronic, B-Cell 497 Squamous Cell Carcinoma of Head and Neck 478 Lymphoma, Follicular 448 Head and Neck Neoplasms 425 Glioblastoma 417 Lymphoma, Large B-Cell, Diffuse 390 Small Cell Lung Carcinoma 384 Leukemia 375 Triple Negative Breast Neoplasms 368 Advanced Solid Tumors 367 Uterine Cervical Neoplasms 362 Urinary Bladder Neoplasms 360

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01431378 2015-12-11

MBIR

GE Healthcare

Lung Neoplasms, Intracranial Hemorrhages, Flank Pain, Urolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡